GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: HR-20013 | HR20013 | Ritanine® (fosrolapitan + palonosetron)
fosrolapitant is an approved drug
Compound class:
Synthetic organic
Comment: Fosrolapitant (HR20013) is rapidly converted to rolapitant which is a selective NK1 receptor antagonist.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. China NMPA (2025) |
| Is prodrug? | Yes |
| Active form | rolapitant |
IUPAC Name ![]() |
| phosphonooxymethyl (5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-2-oxo-8-phenyl-1,9-diazaspiro[4.5]decane-9-carboxylate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13283 | fosrolapitant |
Synonyms ![]() |
| HR-20013 | HR20013 | Ritanine® (fosrolapitan + palonosetron) |
Database Links ![]() |
|
| CAS Registry No. | 2573694-38-7 (source: WHO INN record) |
| GtoPdb PubChem SID | 521588881 |
| PubChem CID | 163871173 |
| Search Google for chemical match using the InChIKey | PKXQGSOAMISYFP-LJXNEXSDSA-N |
| Search Google for chemicals with the same backbone | PKXQGSOAMISYFP |
| Search PubMed clinical trials | fosrolapitant |
| Search PubMed titles | fosrolapitant |
| Search PubMed titles/abstracts | fosrolapitant |
| UniChem Compound Search for chemical match using the InChIKey | PKXQGSOAMISYFP-LJXNEXSDSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | PKXQGSOAMISYFP-LJXNEXSDSA-N |